The role of adipose-derived stem cells in breast cancer progression and metastasis

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Schweizer, Riccardo ^a,b,c   Tsuji, Wakako ^d   Gorantla, Vijay S ^c   Marra, Kacey G ^b,c,e   Rubin, J Peter ^b,c,e   Plock, Jan A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Department of Surgery Shiga Medical Center for Adults   (Japan)

^e University of Pittsburgh   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIN; CD31 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; ENDOGLIN; GROWTH FACTOR; HLA DR ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VIMENTIN;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; BREAST CANCER; BREAST RECONSTRUCTION; CANCER GROWTH; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL MOTILITY; CELL RENEWAL; CELL SURVIVAL; CHONDROGENESIS; CYTOKINE RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; ERYTHROCYTE; EXTRACELLULAR MATRIX; HUMAN; IMMUNOMODULATION; LYMPHOCYTE; MESENCHYMAL STEM CELL; METASTASIS; MORPHOLOGY; MYOFIBROBLAST; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PLEURA EFFUSION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; VASCULARIZATION;

EID: 84929378582     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/120949     Document Type: Review

References (191)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics", CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
2. M. Malvezzi, P. Bertuccio, F. Levi, C. La Vecchia, and E. Negri, "European cancer mortality predictions for the year 2012", Annals of Oncology, vol. 23, no. 4, pp. 1044-1052, 2012.
3. R. Siegel, D. Naishadham, and A. Jemal, "Cancer statistics, 2012", CA: Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10-29, 2012.
4. S. R. Coleman and A. P. Saboeiro, "Fat grafing to the breast revisited: safety and efficacy", Plastic and Reconstructive Surgery, vol. 119, no. 3, pp. 775-785, 2007.
5. L. Zimmerlin, A. D. Donnenberg, J. P. Rubin, P. Basse, R. J. Landreneau, and V. S. Donnenberg, "Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates", This sue Engineering Part A, vol. 17, no. 1-2, pp. 93-106, 2011.
6. R. Calabria and B. Hills, "Fat grafing: fact or fictioň" Aesthetic Surgery Journal, vol. 25, no. 1, article 55, 2005.
7. S.-F. T. Kølle, A. Fischer-Nielsen, A. B. Mathiasen et al., "Enrichment of autologous fat grafs with ex-vivo expanded adipose tissue-derived stem cells for graf survival: a randomised placebo-controlled trial", The Lancet, vol. 382, no. 9898, pp. 1113-1120, 2013.
8. K. Yoshimura, K. Sato, N. Aoi, M. Kurita, T. Hirohi, and K. Harii, "Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells", Aesthetic Plastic Surgery, vol. 32, no. 1, pp. 48-55, 2008.
9. B. J. Philips, T. L. Grahovac, J. E. Valentin et al., "Prevalence of endogenous CD34+ adipose stem cells predicts human fat graf retention in a xenograf model", Plastic and Reconstructive Surgery, vol. 132, no. 4, pp. 845-858, 2013.
10. M. Klinger, F. Caviggioli, F. M. Klinger et al., "Autologous fat graf in scar treatment", The Journal of Craniofacial Surgery, vol. 24, no. 5, pp. 1610-1615, 2013.
11. G. Rigotti, A. Marchi, M. Galiè et al., "Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells", Plastic and Reconstructive Surgery, vol. 119, no. 5, pp. 1409-1424, 2007.
12. P. A. Zuk, M. Zhu, H. Mizuno et al., "Multilineage cells from human adipose tissue: implications for cell-based therapies", This sue Engineering, vol. 7, no. 2, pp. 211-228, 2001.
13. J. M. Gimble, A. J. Katz, and B. A. Bunnell, "Adipose-derived stem cells for regenerative medicine", Circulation Research, vol. 100, no. 9, pp. 1249-1260, 2007.
14. L. E. Kokai, K. Marra, and J. P. Rubin, "Adipose stem cells: biology and clinical applications for tissue repair and regeneration", Translational Research, vol. 163, no. 4, pp. 399-408, 2014.
15. P. A. Zuk, "The adipose-derived stem cell: looking back and looking ahead", Molecular Biology of the Cell, vol. 21, no. 11, pp. 1783-1787, 2010.
16. J. K. Fraser, I. Wulur, Z. Alfonso, and M. H. Hedrick, "Fat tissue: an underappreciated source of stem cells for biotechnology", Trends in Biotechnol ogy, vol. 24, no. 4, pp. 150-154, 2006.
17. M. Zhu, Z. Zhou, Y. Chen et al., "Supplementation of fat grafs with adipose-derived regenerative cells improves long-term graf retention", Annals of Plastic Surgery, vol. 64, no. 2, pp. 222-228, 2010.
18. T. A. Moseley, M. Zhu, and M. H. Hedrick, "Adipose-derived stem and progenitor cells as fllers in plastic and reconstructive surgery", Plastic and Reconstructive Surgery, vol. 118, no. 3S, pp. 121S-128S, 2006.
19. F. Lu, J. Li, J. Gao et al., "Improvement of the survival of human autologous fat transplantation by using VEGF-transfected adipose-derived stem cells", Plastic and Reconstructive Surgery, vol. 124, no. 5, pp. 1437-1446, 2009.
20. S. Schlosser, C. Dennler, R. Schweizer et al., "Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin", Microvascular Research, vol. 83, no. 3, pp. 267-275, 2012.
21. S. Kidd, E. Spaeth, J. L. Dembinski et al., "Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging", Stem Cells, vol. 27, no. 10, pp. 2614-2623, 2009.
22. Y. Zhang, A. C. Daquinag, F. Amaya-Manzanares, O. Sirin, C. Tseng, and M. G. Kolonin, "Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment", Cancer Research, vol. 72, no. 20, pp. 5198-5208, 2012.
23. L. Kucerova, S. Skolekova, M. Matuskova, M. Bohac, and Z. Kozovska, "Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells", BMC Cancer, vol. 13, article 535, 2013.
24. L. Kucerova, V. Altanerova, M. Matuskova, S. Tyciakova, and C. Altaner, "Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy", Cancer Research, vol. 67, no. 13, pp. 6304-6313, 2007.
25. L. Prantl, F. Muehlberg, N. M. Navone et al., "Adipose tissue-derived stem cells promote prostate tumor growth", The Prostate, vol. 70, no. 15, pp. 1709-1715, 2010.
26. A. E. Karnoub, A. B. Dash, A. P. Vo et al., "Mesenchymal stem cells within tumour stroma promote breast cancer metastasis", Nature, vol. 449, no. 7162, pp. 557-563, 2007.
27. M. I. N. Y. Park, Y. O. O. S. Hong, and K. I. M. Sung-Hyun, "Adipose-derived stem cells induced EMT-like changes in H358 lung cancer cells", Anticancer Research, vol. 33, no. 10, pp. 4421-4430, 2013.
28. F. Djouad, P. Plence, C. Bony et al., "Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals", Blood, vol. 102, no. 10, pp. 3837-3844, 2003.
29. L. V. Rhodes, S. E. Muir, S. Elliott et al., "Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence", Breast Cancer Research and Tre atment, vol. 121, no. 2, pp. 293-300, 2010.
30. F. L. Muehlberg, Y.-H. Song, A. Krohn et al., "This sue-resident stem cells promote breast cancer growth and metastasis", Carcinogenesis, vol. 30, no. 4, pp. 589-597, 2009.
31. L. V. Rhodes, J. W. Antoon, S. E. Muir, S. Elliott, B. S. Beckman, and M. E. Burow, "Efects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk", Molecular Cancer, vol. 9, article 295, 2010.
32. A. Y. Khakoo, S. Pati, S. A. Anderson et al., "Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma", The Journal of Experimental Medicine, vol. 203, no. 5, pp. 1235-1247, 2006.
33. L. Qiao, Z. Xu, T. Zhao et al., "Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model", Cell Research, vol. 18, no. 4, pp. 500-507, 2008.
34. K. Otsu, S. Das, S. D. Houser, S. K. Quadri, S. Bhattacharya, and J. Bhattacharya, "Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells", Blood, vol. 113, no. 18, pp. 4197-4205, 2009.
35. A. M. Brewster, G. N. Hortobagyi, K. R. Broglio et al., "Residual risk of breast cancer recurrence 5 years afer adjuvant therapy", Journal of the National Cancer Institute, vol. 100, no. 16, pp. 1179-1183, 2008.
36. E. M. Chandler, B. R. Seo, J. P. Califano et al., "Implanted adipose progenitor cells as physicochemical regulators of breast cancer", Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 25, pp. 9786-9791, 2012.
37. C. Jotzu, E. Alt, G. Welte et al., "Adipose tissue-derived stem cells differentiate into carcinoma-associated fbroblast-like cells under the influence of tumor-derived factors", Analytical Cellular Pathology, vol. 33, no. 2, pp. 61-79, 2010.
38. S. Pinilla, E. Alt, F. J. Abdul Khalek et al., "This sue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion", Cancer Letters, vol. 284, no. 1, pp. 80-85, 2009.
39. B. Dirat, L. Bochet, M. Dabek et al., "Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion", Cancer Research, vol. 71, no. 7, pp. 2455-2465, 2011.
40. V. S. Donnenberg, A. D. Donnenberg, L. Zimmerlin et al., "Localization of CD44 and CD90 positive cells to the invasive front of breast tumors", Cytometry Part B: Clinical Cytometry, vol. 78, no. 5, pp. 287-301, 2010.
41. S. Orecchioni, G. Gregato, I. Martin-Padura et al., "Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer", Cancer Research, vol. 73, no. 19, pp. 5880-5891, 2013.
42. M. Walter, S. Liang, S. Ghosh, P. J. Hornsby, and R. Li, "Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells", Oncogene, vol. 28, no. 30, pp. 2745-2755, 2009.
43. I. Martin-Padura, G. Gregato, P. Marighetti et al., "The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression", Cancer Research, vol. 72, no. 1, pp. 325-334, 2012.
44. F. Bertolini, V. Lohsiriwat, J.-Y. Petit, and M. G. Kolonin, "Adipose tissue cells, lipotransfer and cancer: a challenge for scientists, oncologists and surgeons", Biochimica et Biophysica Acta-Reviews on Cancer, vol. 1826, no. 1, pp. 209-214, 2012.
45. W. Tsuji, J. P. Rubin, and K. G. Marra, "Adipose-derived stem cells: implications in tissue regeneration", World Journal of Stem Cells, vol. 6, no. 3, pp. 312-321, 2014.
46. R. Lin, S. Wang, and R. C. Zhao, "Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model", Molecular and Cellular Biochemistry, vol. 383, no. 1-2, pp. 13-20, 2013.
47. Y. Zhao, J. Gao, and F. Lu, "Human adipose-derived stem cell adipogenesis inducesparacrine regulation of the invasive ability of MCF-7 human breast cancer cells in vitro", Experimental and Terapeutic Medicine, vol. 6, no. 4, pp. 937-942, 2013.
48. J. Yang, L. Xiong, R. Wang, J. Sun, and C. Hirche, "Adiposederived stem cells from the breast", Journal of Research in Medical Sciences, vol. 19, no. 2, pp. 112-116, 2014.
49. B. Sun, K.-H. Roh, J.-R. Park et al., "Terapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model", Cytotherapy, vol. 11, no. 3, pp. 289-298, 2009.
50. C. Zhang, W. Zhai, Y. Xie, Q. Chen, W. Zhu, and X. Sun, "Mesenchymal stem cells derived from breast cancer tissue promote the proliferation and migration of the MCF-7 cell line in vitro", Oncology Letters, vol. 6, no. 6, pp. 1577-1582, 2013.
51. C.-S. Lin, Z.-C. Xin, C.-H. Deng, H. Ning, G. Lin, and T. F. Lue, "Defning adipose tissue-derived stem cells in tissue and in culture", Histology and Histopathology, vol. 25, no. 6, pp. 807-815, 2010.
52. P. E. Engels, M. Tremp, P. J. Kingham et al., "Harvest site influences the growth properties of adipose derived stem cells", Cytotechnology, vol. 65, no. 3, pp. 437-445, 2013.
53. A. E. Aksu, J. P. Rubin, J. R. Dudas, and K. G. Marra, "Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells", Annals of Plastic Surgery, vol. 60, no. 3, pp. 306-322, 2008.
54. B. M. Schipper, K. G. Marra, W. Zhang, A. D. Donnenberg, and J. P. Rubin, "Regional anatomic and age effects on cell function of human adipose-derived stem cells", Annals of Plastic Surgery, vol. 60, no. 5, pp. 538-544, 2008.
55. M. Toyoda, Y. Matsubara, K. Lin, K. Sugimachi, and M. Furue, "Characterization and comparison of adipose tissue-derived cells from human subcutaneous and omental adipose tissues", Cell Biochemistry and Function, vol. 27, no. 7, pp. 440-447, 2009.
56. V. Russo, C. Yu, P. Belliveau, A. Hamilton, and L. E. Flynn, "Comparison of human adipose-derived stem cells isolated from subcutaneous, omental, and intrathoracic adipose tissue depots for regenerative applications", Stem Cells Translational Medicine, vol. 3, no. 2, pp. 206-217, 2014.
57. S. E. Hanson, J. Kim, and P. Hematti, "Comparative analysis of adipose-derived mesenchymal stem cells isolated from abdominal and breast tissue", Aesthetic Surgery Journal, vol. 33, no. 6, pp. 888-898, 2013.
58. D. Trivanović, S. Nikolić, J. Krstić et al., "Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer afected people and their interactions with human breast cancer cell line MCF-7 in vitro", Cell Biology International, vol. 38, no. 2, pp. 254-265, 2014.
59. J. Kim, L. E. Escalante, B. A. Dollar, S. E. Hanson, and P. Hematti, "Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells", Cancer Investigation, vol. 31, no. 8, pp. 550-554, 2013.
60. V. Eterno, A. Zambelli, L. Pavesi et al., "Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling", Oncotarget, vol. 5, no. 3, pp. 613-633, 2014.
61. M. Razmkhah, M. Jaberipour, N. Erfani, M. Habibagahi, A.-R. Talei, and A. Ghaderi, "Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?" Cellular Immunology, vol. 266, no. 2, pp. 116-122, 2011.
62. M. Razmkhah, M. Jaberipour, A. Hosseini, A. Safaei, B. Khalatbari, and A. Ghaderi, "Expression profle of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma", Cellular Immunology, vol. 265, no. 1, pp. 80-85, 2010.
63. L. Zimmerlin, V. S. Donnenberg, M. E. Pfeifer et al., "Stromal vascular progenitors in adult human adipose tissue", Cytometry Part A, vol. 77, no. 1, pp. 22-30, 2010.
64. H. Li, L. Zimmerlin, K. G. Marra, V. S. Donnenberg, A. D. Donnenberg, and J. P. Rubin, "Adipogenic potential of adipose stem cell subpopulations", Plastic and Reconstructive Surgery, vol. 128, no. 3, pp. 663-672, 2011.
65. L. Zimmerlin, V. S. Donnenberg, J. P. Rubin, and A. D. Donnenberg, "Mesenchymal markers on human adipose stem/progenitor cells", Cytometry Part A, vol. 83, no. 1, pp. 134-140, 2013.
66. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defning multipotent mesenchymal stromal cells. The International Society for Cellular Terapy position statement", Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
67. P. Bourin, B. A. Bunnell, L. Casteilla et al., "Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Terapeutics and Science (IFATS) and the International Society for Cellular Terapy (ISCT)", Cytotherapy, vol. 15, no. 6, pp. 641-648, 2013.
68. R. M. Neve, K. Chin, J. Fridlyand et al., "A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes", Cancer Cell, vol. 10, no. 6, pp. 515-527, 2006.
69. D. L. Holliday and V. Speirs, "Choosing the right cell line for breast cancer research", Breast Cancer Research, vol. 13, no. 4, article 215, 2011.
70. E. Devarajan, Y.-H. Song, S. Krishnappa, and E. Alt, "Epithelialmesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells", International Journal of Cancer, vol. 131, no. 5, pp. 1023-1031, 2012.
71. B. G. Rowan, J. M. Gimble, M. Sheng et al., "Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografs", PLoS ONE, vol. 9, no. 2, Article ID e89595, 2014.
72. A. L. Strong, T. A. Strong, L. V. Rhodes et al., "Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways", Breast Cancer Research, vol. 15, no. 5, article R102, 2013.
73. G. Welte, E. Alt, E. Devarajan, S. Krishnappa, C. Jotzu, and Y.-H. Song, "Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion", Molecular Carcinogenesis, vol. 51, no. 11, pp. 861-868, 2012.
74. M. Zhao, P. C. Sachs, X. Wang et al., "Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type", Cancer Biology and Terapy, vol. 13, no. 9, pp. 782-792, 2012.
75. E. Ritter, A. Perry, J. Yu, T. Wang, L. Tang, and E. Bieberich, "Breast cancer cell-derived fbroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells", Annals of Surgery, vol. 247, no. 2, pp. 310-314, 2008.
76. S. Kidd, E. Spaeth, K. Watson et al., "Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma", PLoS ONE, vol. 7, no. 2, Article ID e30563, 2012.
77. A. H. Klopp, E. L. Spaeth, J. L. Dembinski et al., "Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment", Cancer Research, vol. 67, no. 24, pp. 11687-11695, 2007.
78. M. Studeny, F. C. Marini, R. E. Champlin, C. Zompetta, I. J. Fidler, and M. Andreef, "Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors", Cancer Research, vol. 62, no. 13, pp. 3603-3608, 2002.
79. M. Studeny, F. C. Marini, J. L. Dembinski et al., "Mesenchymal stem cells: potential precursors for tumor stroma and targeteddelivery vehicles for anticancer agents", Journal of the National Cancer Institute, vol. 96, no. 21, pp. 1593-1603, 2004.
80. H.-J. Kang, H.-S. Kim, S.-Y. Zhang et al., "Efects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on lef ventricular systolic function and restenosis afer coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial", The Lancet, vol. 363, no. 9411, pp. 751-756, 2004.
81. A. A. Kocher, M. D. Schuster, M. J. Szabolcs et al., "Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function", Nature Medicine, vol. 7, no. 4, pp. 430-436, 2001.
82. J.-X. Yang, N. Zhang, H.-W. Wang, P. Gao, Q.-P. Yang, and Q.-P. Wen, "CXCR4 overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats", The Journal of Biological Chemistry, 2014.
83. N. Liu, A. Patzak, and J. Zhang, "CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury", The American Journal of Physiology-Renal Physiology, vol. 305, no. 7, pp. F1064-F1073, 2013.
84. A. Orimo, P. B. Gupta, D. C. Sgroi et al., "Stromal fbroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion", Cell, vol. 121, no. 3, pp. 335-348, 2005.
85. B. Annabi, Y.-T. Lee, S. Turcotte et al., "Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation", Stem Cells, vol. 21, no. 3, pp. 337-347, 2003.
86. B. Rüster, S. Göttig, R. J. Ludwig et al., "Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells", Blood, vol. 108, no. 12, pp. 3938-3944, 2006.
87. F. Belema-Bedada, S. Uchida, A. Martire, S. Kostin, and T. Braun, "Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2", Cell Stem Cell, vol. 2, no. 6, pp. 566-575, 2008.
88. S. Gehmert, L. Prantl, J. Vykoukal, E. Alt, and Y.-H. Song, "Breast cancer cells attract the migration of adipose tissuederived stem cells via the PDGF-BB/PDGFR-β signaling pathway", Biochemical and Biophysical Research Communications, vol. 398, no. 3, pp. 601-605, 2010.
89. Y. Zhang, A. Daquinag, D. O. Traktuev et al., "White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models", Cancer Research, vol. 69, no. 12, pp. 5259-5266, 2009.
90. B. Ljujic, M. Milovanovic, V. Volarevic et al., "Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice", Scientific Reports, vol. 3, article 2298, 2013.
91. A. P. Molloy, F. T. Martin, R. M. Dwyer et al., "Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells", International Journal of Cancer, vol. 124, no. 2, pp. 326-332, 2009.
92. A. K. Sasser, B. L. Mundy, K. M. Smith et al., "Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments", Cancer Letters, vol. 254, no. 2, pp. 255-264, 2007.
93. L. Kucerova, M. Kovacovicova, S. Polak et al., "Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells", Neoplasma, vol. 58, no. 5, pp. 361-370, 2011.
94. L. Qiao, Z.-L. Xu, T.-J. Zhao, L.-H. Ye, and X.-D. Zhang, "Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling", Cancer Letters, vol. 269, no. 1, pp. 67-77, 2008.
95. B. Sun, K.-R. Yu, D. R. Bhandari, J.-W. Jung, S.-K. Kang, and K.-S. Kang, "Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation", Cancer Letters, vol. 296, no. 2, pp. 178-185, 2010.
96. C.-C. Ke, R.-S. Liu, A. Suetsugu et al., "In vivo fuorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells", PLoS ONE, vol. 8, no. 7, Article ID e69658, 2013.
97. L. Hennighausen and G. W. Robinson, "Information networks in the mammary gland", Nature Reviews Molecular Cell Biology, vol. 6, no. 9, pp. 715-725, 2005.
98. X.-L. Yan, C.-J. Fu, L. Chen et al., "Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway", Breast Cancer Research and Treatment, vol. 132, no. 1, pp. 153-164, 2012.
99. B. S. Wiseman and Z. Werb, "Stromal effectson mammary gland development and breast cancer", Science, vol. 296, no. 5570, pp. 1046-1049, 2002.
100. H. F. Dvorak, "Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing", The New England Journal of Medicine, vol. 315, no. 26, pp. 1650-1659, 1986.
101. P. J. Mishra, P. J. Mishra, R. Humeniuk et al., "Carcinomaassociated fbroblast-like differentiation of human mesenchymal stem cells", Cancer Research, vol. 68, no. 11, pp. 4331-4339, 2008.
102. S. Kidd, E. Spaeth, A. Klopp, M. Andreef, B. Hall, and F. C. Marini, "The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe", Cytotherapy, vol. 10, no. 7, pp. 657-667, 2008.
103. E. L. Spaeth, J. L. Dembinski, A. K. Sasser et al., "Mesenchymal stem cell transition to tumor-associated fbroblasts contributes to fbrovascular network expansion and tumor progression", PLoS ONE, vol. 4, no. 4, Article ID e4992, 2009.
104. Z. Sun, S. Wang, and R. C. Zhao, "The roles of mesenchymal stem cells in tumor infammatory microenvironment", Journal of Hematology & Oncology, vol. 7, article 14, 2014.
105. B. Hall, J. Dembinski, A. K. Sasser, M. Studeny, M. Andreef, and F. Marini, "Mesenchymal stem cells in cancer: tumor-associated fbroblasts and cell-based delivery vehicles", International Journal of Hematology, vol. 86, no. 1, pp. 8-16, 2007.
106. L. Shangguan, X. Ti, U. Krause et al., "Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fbroblasts and abolishes their protumor effects", Stem Cells, vol. 30, no. 12, pp. 2810-2819, 2012.
107. P. Barcellos-de-Souza, V. Gori, F. Bambi, and P. Chiarugi, "Tumor microenvironment: bone marrow-mesenchymal stem cells as key players", Biochimica et Biophysica Acta-Reviews on Cancer, vol. 1836, no. 2, pp. 321-335, 2013.
108. M. Quante, S. P. Tu, H. Tomita et al., "Bone marrow-derived myofbroblasts contribute to the mesenchymal stem cell niche and promote tumor growth", Cancer Cell, vol. 19, no. 2, pp. 257-272, 2011.
109. C. Jotzu, E. Alt, G. Welte et al., "Adipose tissue derived stem cells differentiate into carcinoma-associated fbroblast-like cells under the influence of tumor derived factors", Cellular Oncology, vol. 34, no. 1, pp. 55-67, 2011.
110. M. Ham and A. Moon, "Infammatory and microenvironmental factors involved in breast cancer progression", Archives of Pharmacal Research, vol. 36, no. 12, pp. 1419-1431, 2013.
111. L. M. Coussens and Z. Werb, "Infammatory cells and cancer: think different!", The Journal of Experimental Medicine, vol. 193, no. 6, pp. F23-F26, 2001.
112. E. Y. Lin, A. V. Nguyen, R. G. Russell, and J. W. Pollard, "Colonystimulating factor 1 promotes progression of mammary tumors to malignancy", The Journal of Experimental Medicine, vol. 193, no. 6, pp. 727-740, 2001.
113. A. L. Doedens, C. Stockmann, M. P. Rubinstein et al., "Macrophage expression of hypoxia-inducible factor-1α suppresses T-cell function and promotes tumor progression", Cancer Research, vol. 70, no. 19, pp. 7465-7475, 2010.
114. S. A. Patel, J. R. Meyer, S. J. Greco, K. E. Corcoran, M. Bryan, and P. Rameshwar, "Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cellderived TGF-β", The Journal of Immunology, vol. 184, no. 10, pp. 5885-5894, 2010.
115. C. Senst, T. Nazari-Shafi, S. Kruger et al., "Prospective dual role of mesenchymal stem cells in breast tumor microenvironment", Breast Cancer Research and Treatment, vol. 137, no. 1, pp. 69-79, 2013.
116. G. Xie, Q. Yao, Y. Liu et al., "IL-6-induced epithelialmesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures", International Journal of Oncology, vol. 40, no. 4, pp. 1171-1179, 2012.
117. J.-K. Lee, S.-R. Park, B.-K. Jung et al., "Exosomes derived from mesenchymal stem cells suppress angiogenesis by downregulating VEGF expression in breast cancer cells", PLoS ONE, vol. 8, no. 12, Article ID e84256, 2013.
118. J. Ahn, A. Schatzkin, J. V. Lacey Jr. et al., "Adiposity, adult weight change, and postmenopausal breast cancer risk", Archives of Internal Medicine, vol. 167, no. 19, pp. 2091-2102, 2007.
119. A. H. Eliassen, G. A. Colditz, B. Rosner, W. C. Willett, and S. E. Hankinson, "Adult weight change and risk of postmenopausal breast cancer", The Journal of the American Medical Association, vol. 296, no. 2, pp. 193-201, 2006.
120. Z. Li, S. Bowerman, and D. Heber, "Health ramifications of the obesity epidemic", Surgical Clinics of North America, vol. 85, no. 4, pp. 681-701, 2005.
121. A. R. Carmichael, "Obesity and prognosis of breast cancer", Obesity Reviews, vol. 7, no. 4, pp. 333-340, 2006.
122. A. R. Carmichael, "Obesity as a risk factor for development and poor prognosis of breast cancer", BJOG, vol. 113, no. 10, pp. 1160-1166, 2006.
123. G. Ailhaud, "Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome", Comptes Rendus Biologies, vol. 329, no. 8, pp. 570-577, 2006.
124. P. S. Cooke and A. Naaz, "Role of estrogens in adipocyte development and function", Experimental Biology and Medicine, vol. 229, no. 11, pp. 1127-1135, 2004.
125. M. Hoene and C. Weigert, "The role of interleukin-6 in insulin resistance, body fat distribution and energy balance", Obesity Reviews, vol. 9, no. 1, pp. 20-29, 2008.
126. M. J. Khandekar, P. Cohen, and B. M. Spiegelman, "Molecular mechanisms of cancer development in obesity", Nature Reviews Cancer, vol. 11, no. 12, pp. 886-895, 2011.
127. H. Knüpfer and R. Preiß, "Significance of interleukin-6 (IL-6) in breast cancer (review)", Breast Cancer Research and Treatment, vol. 102, no. 2, pp. 129-135, 2007.
128. A. W. Studebaker, G. Storci, J. L. Werbeck et al., "Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner", Cancer Research, vol. 68, no. 21, pp. 9087-9095, 2008.
129. D. S. Hong, L. S. Angelo, and R. Kurzrock, "Interleukin-6 and its receptor in cancer: implications for translational therapeutics", Cancer, vol. 110, no. 9, pp. 1911-1928, 2007.
130. N. J. Sullivan, A. K. Sasser, A. E. Axel et al., "Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells", Oncogene, vol. 28, no. 33, pp. 2940-2947, 2009.
131. C. A. Gilbert and J. M. Slingerland, "Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression", Annual Review of Medicine, vol. 64, pp. 45-57, 2013.
132. R. R. Gonzalez, A. Watters, Y. Xu et al., "Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer", Breast Cancer Research, vol. 11, no. 3, article R36, 2009.
133. K. J. Davies, "The complex interaction of Matrix Metalloproteinases in the migration of cancer cells through breast tissue stroma", International Journal of Breast Cancer, vol. 2014, Article ID 839094, 5 pages, 2014.
134. L. M. Martinez, V. B. F. Vallone, V. Labovsky et al., "Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases", Clinical & Experimental Metastasis, vol. 31, no. 2, pp. 213-232, 2014.
135. Y. Sun, X. Mao, C. Fan et al., "CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis", Tumor Biology, vol. 35, no. 8, pp. 7765-7773, 2014.
136. K. E. Corcoran, K. A. Trzaska, H. Fernandes et al., "Mesenchymal stem cells in early entry of breast cancer into bone marrow", PLoS ONE, vol. 3, no. 6, Article ID e2563, 2008.
137. C. Yao, Y. Lin, M.-S. Chua et al., "Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells", International Journal of Cancer, vol. 121, no. 9, pp. 1949-1957, 2007.
138. D. Raman, P. J. Baugher, Y. M. Tu, and A. Richmond, "Role of chemokines in tumor growth", Cancer Letters, vol. 256, no. 2, pp. 137-165, 2007.
139. A. Freund, C. Chauveau, J.-P. Brouillet et al., "IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells", Oncogene, vol. 22, no. 2, pp. 256-265, 2003.
140. E. R. Motrescu and M.-C. Rio, "Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle", Biological Chemistry, vol. 389, no. 8, pp. 1037-1041, 2008.
141. C. Mehner, A. Hockla, E. Miller, S. Ran, D. C. Radisky, and E. S. Radisky, "Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basallike triple negative breast cancer", Oncotarget, vol. 5, no. 9, pp. 2736-2749, 2014.
142. S. B. Somiari, C. D. Shriver, C. Heckman et al., "Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer", Cancer Letters, vol. 233, no. 1, pp. 98-107, 2006.
143. H. Hombauer and J. J. Minguell, "Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells", British Journal of Cancer, vol. 82, no. 7, pp. 1290-1296, 2000.
144. F. A. Fierro, W. D. Sierralta, M. J. Epuñan, and J. J. Minguell, "Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination", Clinical & Experimental Metastasis, vol. 21, no. 4, pp. 313-319, 2004.
145. R. Kalluri and R. A. Weinberg, "The basics of epithelialmesenchymal transition", The Journal of Clinical Investigation, vol. 119, no. 6, pp. 1420-1428, 2009.
146. L. Chen, A. Mizutani, T. Kasai et al., "Mouse induced pluripotent stem cell microenvironment generates epithelialmesenchymal transition in mouse Lewis lung cancer cells", The American Journal of Cancer Research, vol. 4, no. 1, pp. 80-84, 2014.
147. S. Sethi, J. Macoska, W. Chen, and F. H. Sarkar, "Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis", American Journal of Translational Research, vol. 3, no. 1, pp. 90-99, 2010.
148. M. Emadi Baygi, Z. S. Soheili, I. Schmitz, S. Sameie, and W. A. Schulz, "Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines", Cell Biology and Toxicology, vol. 26, no. 6, pp. 553-567, 2010.
149. L. E. Lindley and K. J. Briegel, "Molecular characterization of TGFβ-induced epithelial-mesenchymal transition in normal fnite lifespan human mammary epithelial cells", Biochemical and Biophysical Research Communications, vol. 399, no. 4, pp. 659-664, 2010.
150. Y. Choi, H. J. Lee, M. H. Jang et al., "Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer", Human Pathology, vol. 44, no. 11, pp. 2581-2589, 2013.
151. L. J. Talbot, S. D. Bhattacharya, and P. C. Kuo, "Epithelialmesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies", International Journal of Biochemistry and Molecular Biology, vol. 3, no. 2, pp. 117-136, 2012.
152. A. H. Klopp, L. Lacerda, A. Gupta et al., "Mesenchymal stem cells promote mammosphere formation and decrease E-Cadherin in normal and malignant breast cells", PLoS ONE, vol. 5, no. 8, Article ID e12180, 2010.
153. P. C. Wang, C. C. Weng, Y. S. Hou et al., "Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells", International Journal of Molecular Sciences, vol. 15, no. 3, pp. 3560-3579, 2014.
154. R. Singh, B. S. Shankar, and K. B. Sainis, "TGF-β1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells", Cellular Signalling, vol. 26, no. 7, pp. 1604-1615, 2014.
155. P. B. Sehgal, "Interleukin-6 induces increased motility, cell-cell and cell-substrate dyshesion and epithelial-to-mesenchymal transformation in breast cancer cells", Oncogene, vol. 29, no. 17, pp. 2599-2600, 2010.
156. B. Jovanović, J. S. Beeler, M. W. Pickup et al., "Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer", Breast Cancer Research, vol. 16, no. 4, article R69, 2014.
157. I. Espinoza, R. Pochampally, F. Xing, K. Watabe, and L. Miele, "Notch signaling: targeting cancer stem cells and epithelial-tomesenchymal transition", OncoTargets and Terapy, vol. 6, pp. 1249-1259, 2013.
158. D. Yan, D. Avtanski, N. K. Saxena, and D. Sharma, "Leptininduced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways", The Journal of Biological Chemistry, vol. 287, no. 11, pp. 8598-8612, 2012.
159. N. Y. Li, C. E. Weber, P. Y. Wai et al., "An MAPK-dependent pathway induces epithelial-mesenchymal transition via Twist activation in human breast cancer cell lines", Surgery, vol. 154, no. 2, pp. 404-410, 2013.
160. A. Giordano, H. Gao, S. Anfossi et al., "Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer", Molecular Cancer Terapeutics, vol. 11, no. 11, pp. 2526-2534, 2012.
161. S. Muenst, S. Däster, E. C. Obermann et al., "Nuclear expression of snail is an independent negative prognostic factor in human breast cancer", Disease Markers, vol. 35, no. 5, pp. 337-344, 2013.
162. C. P. El-Haibi, G. W. Bell, J. Zhang et al., "Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy", Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 43, pp. 17460-17465, 2012.
163. X.-H. Pei, X.-Q. Lv, and H.-X. Li, "Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1", Biochemical and Biophysical Research Communications, vol. 446, no. 1, pp. 322-327, 2014.
164. Y. Yu, C.-H. Xiao, L.-D. Tan, Q.-S. Wang, X.-Q. Li, and Y.-M. Feng, "Cancer-associated fbroblasts induce epithelialmesenchymal transition of breast cancer cells through paracrine TGF-β signalling", British Journal of Cancer, vol. 110, no. 3, pp. 724-732, 2014.
165. T. E. Anwar and C. G. Kleer, "This sue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer", Human Pathology, vol. 44, no. 8, pp. 1457-1464, 2013.
166. S. A. Mani, W. Guo, M.-J. Liao et al., "The epithelialmesenchymal transition generates cells with properties of stem cells", Cell, vol. 133, no. 4, pp. 704-715, 2008.
167. C. Oliveras-Ferraros, B. Corominas-Faja, S. A. Vazquez-Martin et al., "Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)", Cell Cycle, vol. 11, no. 21, pp. 4020-4032, 2012.
168. S. Al Saleh, L. H. Sharaf, and Y. A. Luqmani, "Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review)", International Journal of Oncology, vol. 38, no. 5, pp. 1197-1217, 2011.
169. D. Lesniak, S. Sabri, Y. Xu et al., "Spontaneous epithelialmesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer", PLoS ONE, vol. 8, no. 8, Article ID e71987, 2013.
170. T. Tanei, K. Morimoto, K. Shimazu et al., "Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers", Clinical Cancer Research, vol. 15, no. 12, pp. 4234-4241, 2009.
171. M. C. Missana, I. Laurent, L. Barreau, and C. Balleyguier, "Autologous fat transfer in reconstructive breast surgery: indications, technique and results", European Journal of Surgical Oncology, vol. 33, no. 6, pp. 685-690, 2007.
172. D.-N. Zheng, Q.-F. Li, H. Lei et al., "Autologous fat grafing to the breast for cosmetic enhancement: experience in 66 patients with long-term follow up", Journal of Plastic, Reconstructive & Aesthetic Surgery, vol. 61, no. 7, pp. 792-798, 2008.
173. E. Delay, S. Garson, G. Tousson, and R. Sinna, "Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years", Aesthetic Surgery Journal, vol. 29, no. 5, pp. 360-376, 2009.
174. J. Y. Petit, V. Lohsiriwat, K. B. Clough et al., "The oncologic outcome and immediate surgical complications of lipoflling in breast cancer patients: a multicenter study-milan-parislyon experience of 646 lipoflling procedures", Plastic and Reconstructive Surgery, vol. 128, no. 2, pp. 341-346, 2011.
175. J. Y. Petit, E. Botteri, V. Lohsiriwat et al., "Locoregional recurrence risk afer lipoflling in breast cancer patients", Annals of Oncology, vol. 23, no. 3, pp. 582-588, 2012.
176. J. Y. Petit, M. Rietjens, E. Botteri et al., "Evaluation of fat grafing safety in patients with intra epithelial neoplasia: a matchedcohort study", Annals of Oncology, vol. 24, no. 6, pp. 1479-1484, 2013.
177. Y. G. Illouz and A. Sterodimas, "Autologous fat transplantation to the breast: a personal technique with 25 years of experience", Aesthetic Plastic Surgery, vol. 33, no. 5, pp. 706-715, 2009.
178. J. M. Smit, H. J. P. Tielemans, B. De Vries, and S. M. H. Tuinder, "Recurrence of invasive ductal breast carcinoma 10 months afer autologous fat grafing", Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 67, no. 5, pp. e127-e128, 2014.
179. B. Chaput, L. Foucras, S. Le Guellec, J. L. Grolleau, and I. Garrido, "Recurrence of an invasive ductal breast carcinoma 4 months afer autologous fat grafing", Plastic & Reconstructive Surgery, vol. 131, no. 1, pp. 123e-124e, 2013.
180. B. Chaput, J. L. Grolleau, N. Bertheuil, H. Eburdery, J. P. Chavoin, and I. Garrido, "Another suspected case of breast cancer recurrence afer lipofllinʇ Remain cautious...", Journal of Plastic, Reconstructive and Aesthetic Surgery, 2014.
181. R. Pérez-Cano, J. J. Vranckx, J. M. Lasso et al., "Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafing for partial mastectomy deffects: the RESTORE-2 trial", European Journal of Surgical Oncology, vol. 38, no. 5, pp. 382-389, 2012.
182. F. M. Lampert, S. Grabin, and G. Björn Stark, "The RESTORE-2 trial: proof of safety and efficacy of 'regenerative-cell enriched' fat-grafinʇ" European Journal of Surgical Oncology, vol. 38, no. 12, pp. 1231-1232, 2012.
183. F. De Lorenzi, V. Lohsiriwat, and J. Y. Petit, "In response to: Rigotti G, Marchi A, Stringhini P et al. 'Determining the oncological risk of autologous lipoaspirate grafing for postmastectomy breast reconstruction'. Aesth Plast Surg 2010;34:475", Aesthetic Plastic Surgery, vol. 35, no. 1, pp. 132-133, 2011.
184. T. K. Krastev, Y. Jonasse, and M. Kon, "Oncological safety of autologous lipoaspirate grafing in breast cancer patients: a systematic review", Annals of Surgical Oncology, vol. 20, no. 1, pp. 111-119, 2013.
185. F. Claro Jr., J. C. A. Figueiredo, A. G. Zampar, and A. M. Pinto-Neto, "Applicability and safety of autologous fat for reconstruction of the breast", The British Journal of Surgery, vol. 99, no. 6, pp. 768-780, 2012.
186. M. Alharbi, I. Garrido, C. Vaysse, J. P. Chavoin, J. L. Grolleau, and B. Chaput, "Latissimus dorsi fap invasion by ductal breast carcinoma afer lipoflling", Plastic and Reconstructive Surgery-Global Open, vol. 1, no. 8, p. e68, 2013.
187. S. E. Burdall, A. M. Hanby, M. R. J. Lansdown, and V. Speirs, "Breast cancer cell lines: friend or foe?" Breast Cancer Research, vol. 5, no. 2, pp. 89-95, 2003.
188. A. Krumboeck, P. Giovanoli, and J. A. Plock, "Fat grafing and stem cell enhanced fat grafing to the breast under oncological aspects - Recommendations for patient selection", Breast, vol. 22, no. 5, pp. 579-584, 2013.
189. K. A. Gutowski, S. B. Baker, S. R. Coleman et al., "Current applications and safety of autologous fat grafs: a report of the ASPS Fat Graf Task Force", Plastic and Reconstructive Surgery, vol. 124, no. 1, pp. 272-280, 2009.
190. SOFCPRE, "Recommandations concernant les transferts de graisse dans le sein", 2012.
191. P. A. Kenny, G. Y. Lee, C. A. Myers et al., "The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profles of gene expression", Molecular Oncology, vol. 1, no. 1, pp. 84-96, 2007.